transact human cd3 cd28 activator (Miltenyi Biotec)
Miltenyi Biotec is a verified supplier 
Miltenyi Biotec manufactures this product 
97
Structured Review
Miltenyi Biotec
transact human cd3 cd28 activator
Transact Human Cd3 Cd28 Activator, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 578 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd3+cd28+transact/T+Cell+TransAct+%2C+human/pmc13168688-350-11-15
Average 97 stars, based on 578 article reviews
Transact Human Cd3 Cd28 Activator, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 578 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd3+cd28+transact/T+Cell+TransAct+%2C+human/pmc13168688-350-11-15
Average 97 stars, based on 578 article reviews
transact human cd3 cd28 activator - by Bioz Stars,
2026-10
97/100 stars
Images
Related Articles
Activation Assay:Article Title: Cryopreserved leukapheresis enables scalable and distributed CAR-T manufacturing: a multi-platform comparative study Article Snippet: T cell purification: T cells were isolated from leukapheresis-derived cells (1 × 10 7 cells) using CliniMACS CD4 and CD8 Microbeads (2 μL each) for magnetic separation, enriching CD4 + and CD8 + populations. .. T cell activation: Purified T cells were activated with Article Title: CD4⁺ T cells confer transplantable rejuvenation via Rivers of telomeres Article Snippet: .. Supernatants containing APC telomere vesicles were added to autologous purified CD4+ T cells, followed by activation with Article Title: Tailoring capsid-directed evolution technology for improved AAV-mediated CAR-T generation. Article Snippet: 1Translational Vectorology Research Unit, Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia; 2Infection, Immunity and Inflammation Research and Teaching Department, Great Ormond Street Institute of Child Health, University College, London, UK; 3Children’s Cancer Research Unit, Kids Research, The Children’s Hospital at Westmead, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia; 4Australian e-Health Research Centre, Commonwealth Scientific and Industrial Research Organisation, Sydney, NSW, Australia; 5Vector and Genome Engineering Facility, Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia; 6Australian Genome Therapeutics Centre, Children’s Medical Research Institute and Sydney Children’s Hospitals Network, Westmead, NSW 2145, Australia; 7Laboratory of Molecular Oncology and Innovative Therapies, Military Institute of Medicine National Research Institute, Warsaw, Poland Purification:Article Title: Cryopreserved leukapheresis enables scalable and distributed CAR-T manufacturing: a multi-platform comparative study Article Snippet: T cell purification: T cells were isolated from leukapheresis-derived cells (1 × 10 7 cells) using CliniMACS CD4 and CD8 Microbeads (2 μL each) for magnetic separation, enriching CD4 + and CD8 + populations. .. T cell activation: Purified T cells were activated with Article Title: CD4⁺ T cells confer transplantable rejuvenation via Rivers of telomeres Article Snippet: .. Supernatants containing APC telomere vesicles were added to autologous purified CD4+ T cells, followed by activation with Concentration Assay:Article Title: Cryopreserved leukapheresis enables scalable and distributed CAR-T manufacturing: a multi-platform comparative study Article Snippet: T cell purification: T cells were isolated from leukapheresis-derived cells (1 × 10 7 cells) using CliniMACS CD4 and CD8 Microbeads (2 μL each) for magnetic separation, enriching CD4 + and CD8 + populations. .. T cell activation: Purified T cells were activated with Isolation:Article Title: Tailoring capsid-directed evolution technology for improved AAV-mediated CAR-T generation. Article Snippet: 1Translational Vectorology Research Unit, Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia; 2Infection, Immunity and Inflammation Research and Teaching Department, Great Ormond Street Institute of Child Health, University College, London, UK; 3Children’s Cancer Research Unit, Kids Research, The Children’s Hospital at Westmead, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia; 4Australian e-Health Research Centre, Commonwealth Scientific and Industrial Research Organisation, Sydney, NSW, Australia; 5Vector and Genome Engineering Facility, Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia; 6Australian Genome Therapeutics Centre, Children’s Medical Research Institute and Sydney Children’s Hospitals Network, Westmead, NSW 2145, Australia; 7Laboratory of Molecular Oncology and Innovative Therapies, Military Institute of Medicine National Research Institute, Warsaw, Poland |